跳至主要内容
临床试验/DRKS00020121
DRKS00020121招募中不适用

Biodegradable magnesium-based PIP arthrodesis for the treatment of lesser toe deformities: a post market clinical follow-up study - TOEMAG

Syntellix AG0 个研究点目标入组 40 人开始时间: 2019年12月11日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Syntellix AG
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Indication for proximal interphalangeal joint fusion (hammer toe) of lesser toes with or without concurrent hallux valgus surgery.
  • Operation technique in case of concurrent hallux valgus surgery on the same foot: Chevron, Chevron/Akin, Scarf or McBride.
  • Age =18 years.
  • Written informed consent.

排除标准

  • Pregnancy, suspected pregnancy or breast feeding.
  • Severe hallux valgus.
  • Concurrent operation on the other foot.
  • Osteoporosis.
  • Insufficient or avascular bone mass for anchorage of the implant.
  • Peripheral arterial occlusive disease.
  • Complex regional pain syndrome (CRPS).
  • Confirmation or suspected septic infectious surgical site.
  • Luxation of the metatarsophalangeal joint.
  • Relevant neurological or psychiatric disorder, e.g., epilepsy.
  • Restricted mobility which could curtail postoperative healing

研究者

发起方
Syntellix AG

相似试验